首页> 外文期刊>British journal of ophthalmology >Established and emerging ancillary techniques in management of microbial keratitis: a review
【24h】

Established and emerging ancillary techniques in management of microbial keratitis: a review

机译:建立和新兴的辅助技术治疗微生物性角膜炎:审查。

获取原文
获取原文并翻译 | 示例
       

摘要

Microbial keratitis is a sight-threatening condition and an ocular emergency, because of the potential for rapid progression. Intensive topical antimicrobials are the mainstay and the gold standard of treatment for microbial keratitis. However, despite appropriate diagnosis and therapy, treatment failure is still common, and can result in significant morbidity due to corneal perforation and/or scarring. For this reason, clinicians continue to seek novel treatment techniques in order to expand the armamentarium of tools available to manage microbial keratitis, and in doing so improve clinical outcomes. In this review, we examine the evidence for some established, as well as a few emerging ancillary techniques used to manage microbial keratitis. These include topical corticosteroids, corneal collagen cross-linking, intrastromal antimicrobials, amniotic membrane transplantation and miscellaneous other techniques. Of these, collagen cross-linking shows some promise for selected cases of infectious keratitis, although more research in the area is required before it is accepted as mainstream treatment for this potentially blinding condition.
机译:微生物性角膜炎是一种威胁视力的疾病,是一种眼部急症,因为它具有快速发展的潜力。密集的局部抗菌药物是治疗微生物性角膜炎的主要手段和黄金标准。然而,尽管进行了适当的诊断和治疗,治疗失败仍然很常见,并且由于角膜穿孔和/或疤痕形成会导致严重的发病率。因此,临床医生继续寻求新颖的治疗技术,以扩展可用于管理微生物性角膜炎的工具的设备,并以此改善临床效果。在这篇综述中,我们检查了一些已建立的证据,以及一些用于管理微生物性角膜炎的新兴辅助技术的证据。这些措施包括局部使用皮质类固醇,角膜胶原交联,基质内抗菌剂,羊膜移植和其他多种技术。其中,胶原蛋白交联对某些感染性角膜炎病例显示出一定的希望,尽管在被接受为这种潜在致盲性疾病的主流治疗方法之前,还需要对该领域进行更多的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号